Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Curiel, Tyler J., Wei, Shuang, Dong, Haidong, Alvarez, Xavier, Cheng, Pui, Mottram, Peter, Krzysiek, Roman, Knutson, Keith L. +14 more·2003·Nature Medicine

DOI 10.1038/nm863

Cited by (1,000)

Items 601–700 of 1,000

Significance of B7-H1 Overexpression in Kidney Cancer
Robert Houston Thompson, Eugene D. Kwon · 2006 · Clinical Genitourinary Cancer
Therapeutics targeting tumor immune escape: Towards the development of new generation anticancer vaccines
Simone Mocellin M. D, Donato Nitti · 2007 · Medicinal Research Reviews
A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling
Songwen Ju, Songguang Ju, Yan Ge, Hong-Xia Qiu, Binfeng Lu, Yuhua Qiu, Jingxiang Fu, Gaoqin Liu, Qin Wang, Yumin Hu et al. · 2009 · International Immunology
Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data
Hansen, Torben Frøstrup, Qvortrup, Camilla, Pfeiffer, Per · 2021 · Cancers
ROTACs leverage signaling-incompetent R-spondin for targeted protein degradation
Rui Sun, Zibo Meng, Hye-Yoon Lee, Rienk Offringa, Christof Niehrs · 2023 · Cell chemical biology
Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL 1 transgenic mouse model
Franz Josef Gassner, Nadja Zaborsky, Kemal Catakovic, Stefan Rebhandl, Michael Huemer, Alexander Egle, Tanja Nicole Hartmann, Richard Greil, Roland Geisberger · 2015 · British Journal of Haematology
Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Elaine O. Bigelow, Katherine M. Bever, Haiying Xu, Allison Yager, Annie A. Wu, Janis Marie Taube, Lieping Chen, Elizabeth M. Jaffee, Robert A. Anders, Lei Zheng · 2013 · Journal of Visualized Experiments
Keratinocyte-Associated B7-H1 Directly Regulates Cutaneous Effector CD8+ T Cell Responses
Patcharee Ritprajak, Masaaki Hashiguchi, Fumihiko Tsushima, Narumon Chalermsarp, Miyuki Azuma · 2010 · The Journal of Immunology
Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8+ T Lymphocytes in Ovarian Carcinosarcoma
Jun Zhu, Hao Wen, Xingzhu Ju, Rui Bi, Wen‐Jia Zuo, Xiaohua Wu · 2017 · PLoS ONE
Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model
Jessie R. Nedrow, Anders Josefsson, Sunju Park, Tom A. Bäck, Robert F. Hobbs, Cory F. Brayton, Frank Bruchertseifer, Alfred Morgenstern, George Sgouros · 2017 · EJNMMI Research
Maturation-Resistant Dendritic Cells Induce Hyporesponsiveness in Alloreactive CD45RA+ and CD45RO+ T-Cell Populations
Andrea M. Woltman, Sandra W. van der Kooij, Johan Willem de Fijter, Cees van Kooten · 2006 · American Journal of Transplantation
Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines
Barbara A. Fox, Kiah L. Sanders, Shan Chen, David J. Bzik · 2013 · Trends in Parasitology
Obesity-associated cancer: an immunological perspective
Melissa Jane Conroy, Margaret R. Dunne, Claire L. Donohoe, John Vincent Reynolds · 2015 · Proceedings of The Nutrition Society
PD-L1 induction via the MEK-JNK-AP1 axis by a neddylation inhibitor promotes cancer-associated immunosuppression
Shizhen Zhang, Xia-Hong You, Tiantian Xu, Qian Chen, Hua Li, Longyu Dou, Yilun Sun, Xiufang Xiong, Morgan A. Meredith, Yi Sun · 2022 · Cell Death and Disease
TIE-2 and VEGFR Kinase Activities Drive Immunosuppressive Function of TIE-2–Expressing Monocytes in Human Breast Tumors
Mark R. Ibberson, Sylvian Bron, Nicolas Guex, Eveline Faes-van’t Hull, Assia Ifticene‐Treboux, Luc Henry, Hans‐Anton Lehr, Jean-François Delaloye, George Coukos, Ioannis Xénarios et al. · 2013 · Clinical Cancer Research
The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer
Brian S. Henick, Roy S. Herbst, Sarah B. Goldberg · 2014 · Expert Opinion on Therapeutic Targets
Crystal clear: visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies
Shuguang Tan, Danqing Chen, Kefang Liu, Mengnan He, Hao Song, Yi Shi, Jun Liu, Catherine W.-H. Zhang, Jianxun Qi, Jinghua Yan et al. · 2016 · Protein & Cell
Regulatory function of cytomegalovirus-specific CD4+CD27−CD28− T cells
Adriana Tovar-Salazar, Julie Patterson‐Bartlett, Renee D. Jesser, Adriana Weinberg · 2009 · Virology
The Promise of Preventive Cancer Vaccines
Pier‐Luigi Lollini, Federica Cavallo, Patrizia Nanni, Elena Quaglino · 2015 · Vaccines
Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy
Mohamed Labib Salem · 2015 · World Journal of Hepatology
Costimulatory molecule B7-H1 on the immune escape of bladder cancer and its clinical significance
Yonghua Wang, Qianyuan Zhuang, Siwei Zhou, Zhiquan Hu, Ruzhu Lan · 2009 · Journal of Huazhong University of Science and Technology [Medical Sciences]
Programmed Death 1 Pathway inhibition in Metastatic Renal Cell Cancer and Prostate Cancer
Patricia A. Tang, Daniel Yick Chin Heng · 2012 · Current Oncology Reports
Autologous stromal vascular fraction cells: A tool for facilitating tolerance in rheumatic disease
Thomas E. Ichim, Robert J. Harman, Wei‐Ping Min, Boris Minev, Fabio Solano, Jorge Paz Rodríguez, Doru T Alexandrescu, Rosalia de Necochea-Campion, Xiang Hu, Annette M. Marleau et al. · 2010 · Cellular Immunology
Role of the PD‐1/PD‐L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions
Yan Mi, Jinming Han, Jie Zhu, Tao Jin · 2021 · Molecular Neurobiology
B7‐H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL‐10 levels
Lei Geng, G. Jiang, Yun Hua Fang, Shengzhang Dong, Haiyang Xie, Y. Chen, Miaoda Shen, Shusen Zheng · 2006 · Journal of Viral Hepatitis
High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals
Hee Kyung Kim, Hongbing Guan, Guorui Zu, Hui Joyce Li, Lizhi Wu, Feng Xu, Craig A. Elmets, Yang‐Xin Fu, Hui Xu · 2006 · Journal of Leukocyte Biology
Assays for predicting and monitoring responses to lung cancer immunotherapy.
Cristina Teixidó, Niki Karachaliou, María González‐Cao, Daniela Morales-Espinosa, Rafael Rosell · 2015 · Europe PMC (PubMed Central)
Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia
Maciej Grzywnowicz, Agnieszka Karczmarczyk, Katarzyna Skórka, M Zajac, Joanna Zaleska, Sylwia Chocholska, Waldemar Tomczak, Krzysztof Giannopoulos · 2015 · Acta Haematologica
Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application
Tom A. Mulder, Björn Engelbrekt Wahlin, Anders Österborg, Marzia Palma · 2019 · Cancers
Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands
Juliana Idoyaga, Jose G. Moreno, Laura C. Bonifaz · 2007 · Cancer Immunology Immunotherapy
How metabolism bridles cytotoxic CD8+ T cells through epigenetic modifications
Heleen H. Van Acker, Shixin Ma, Tommaso Scolaro, Susan M. Kaech, Massimiliano Mazzone · 2021 · Trends in Immunology
Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine
Chao Mei, Wei‐Jing Gong, Xu Wang, Yongning Lv, Yu Zhang, Sanlan Wu, Chunqi Zhu · 2023 · Frontiers in Pharmacology
B7-H1 enhances proliferation ability of gastric cancer stem-like cells as a receptor
YUPENG YANG, KE WU, Ende Zhao, Wei Li, Liang Shi, Gengchen Xie, Bin Jiang, Yaxin Wang, Ruidong Li, Peng Zhang et al. · 2015 · Oncology Letters
Antigen-Presenting Cell (APC) Subsets in Ovarian Cancer
Cailin Moira Wilke, Ilona Kryczek, Weiping Zou · 2011 · International Reviews of Immunology
Phagocytosis, a Potential Mechanism for Myeloid-Derived Suppressor Cell Regulation of CD8+ T Cell Function Mediated through Programmed Cell Death-1 and Programmed Cell Death-1 Ligand Interaction
Young‐June Kim, Su-Jung Park, Hal E. Broxmeyer · 2011 · The Journal of Immunology
Mechanistic insights into cancer immunity and immunotherapy
Weiping Zou · 2018 · Cellular and Molecular Immunology
A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity
Wenqiang Shi, Liangyin Lv, Nan Liu, Hui Wang, Yang Wang, Wen Zhu, Zexin Liu, Jianwei Zhu, Huili Lu · 2022 · Molecular Therapy
PD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapy.
Kaimin Xiao, Silin Zhang, Qi Peng, Yuxia Du, Xiyue Yao, Ian-Ian Ng, Haidong Tang · 2024 · Cell Reports
An OMV‐Based Nanovaccine as Antigen Presentation Signal Enhancer for Cancer Immunotherapy
Yichao Lu, Nana Ma, Keman Cheng, Guangna Liu, Jie Liang, Xu Chen, Danrui Li, Cheng Cao, Xiaoyu Gao, Liting Chen et al. · 2025 · Advanced Materials
Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
Cailin Moira Wilke, Lin Wang, Shuang Wei, Ilona Kryczek, Emina H. Huang, John Y. Kao, Yanwei Lin, Jing‐Yuan Fang, Weiping Zou · 2011 · Journal of Translational Medicine
Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout
Shuai Zhen, Jiaojiao Lu, Wei Chen, Le Zhao, Li Xu · 2018 · Human Gene Therapy
Integrated immune gene expression signature and molecular classification in gastric cancer: New insights
Maria Grazia Refolo, Claudio Lotesoriere, Caterina Messa, Maria Gabriella Caruso, Rosalba D’Alessandro · 2020 · Journal of Leukocyte Biology
Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity
Yuankun Zhang, Qingxiao Song, Kaniel M. Cassady, Michael Lee, Haidong Tang, Moqian Zheng, Bixin Wang, Dustin E. Schones, Yang‐Xin Fu, Arthur D. Riggs et al. · 2023 · Proceedings of the National Academy of Sciences
Signaling by Type I Interferons in Immune Cells: Disease Consequences
Μαρκέλλα Ζαννίκου, Eleanor N. Fish, Leonidas C. Platanias · 2024 · Cancers
Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications
Janani Kumar, Alister C. Ward · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
The PD-1:PD-L1 immune inhibitory checkpoint in Helicobacter pylori infection and gastric cancer: a comprehensive review and future perspectives
Rui Silva, Irene Gullo, Fátima Carneiro · 2016 · Porto Biomedical Journal
Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma
Amy K. Kim, Faiz Gani, Andrew J. Layman, Sepideh Besharati, Qingfeng Zhu, Farah Succaria, Elizabeth L. Engle, Feriyl Bhaijee, Maria B. Goggins, Nicolas Jose Llosa et al. · 2019 · Cancer Immunology Research
Triptolide reverses helper T cell inhibition and down-regulates IFN-γ induced PD-L1 expression in glioma cell lines
Lei Zhang, John S. Yu · 2019 · Journal of Neuro-Oncology
Crystal structure of PD-1 in complex with an antibody-drug tislelizumab used in tumor immune checkpoint therapy
Sang Hyung Lee, Hyun Tae Lee, Heejin Lim, Yu-Jin Kim, Ui Beom Park, Yong‐Seok Heo · 2020 · Biochemical and Biophysical Research Communications
Oncometabolites—A Link between Cancer Cells and Tumor Microenvironment
Maksymilian Baryła, Aleksandra Semeniuk-Wojtaś, Letycja Róg, Leszek Kraj, Maciej Małyszko, Rafał Stec · 2022 · Biology
Characterization and application of two novel monoclonal antibodies against 2IgB7‐H3: expression analysis of 2IgB7‐H3 on dendritic cells and tumor cells
G.‐B. Zhang, Huan Zhou, Y.‐J. Chen, Yan Ge, Fang Xie, Qin Shi, Huanfei Ma, Mintian Fei, Xueguang Zhang · 2005 · Tissue Antigens
Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence
Christina Wefers, Laurens J. Lambert, Ruurd Torensma, Stanleyson V. Hato · 2015 · Gynecologic Oncology
Cytokine induced expression of programmed death ligands in human neutrophils
Paul E. Bankey, Sanjib Banerjee, Andrea Zucchiatti, Mita De, Rami W. Sleem, Chuen-Fu Linda Lin, Carol L. Miller‐Graziano, Asit Kumar De · 2010 · Immunology Letters
Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
Seyed Hossein Kiaie, Mohammad‐Javad Sanaei, Masoud Heshmati, Zahra Asadzadeh, Iman Azimi, Saleh Hadidi, Reza Jafari, Behzad Baradaran · 2020 · Acta Pharmaceutica Sinica B
Molecular basis of PD-1 blockade by dostarlimab, the FDA-approved antibody for cancer immunotherapy
Ui Beom Park, Tae Jun Jeong, Nahyeon Gu, Hyun Tae Lee, Yong‐Seok Heo · 2022 · Biochemical and Biophysical Research Communications
Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML
Anudishi Tyagi, Stanley Ly, Fouad El-Dana, Bin Yuan, Appalaraju Jaggupilli, Sabrina Grimm, Marina Y Konopleva, Hans‐Jörg Bühring, Venkata Lokesh Battula · 2022 · Blood
The Immune Microenvironment in Gastric Cancer: Prognostic Prediction
Mingwei Ma, Juan Sun, Zhen Liu, Siwen Ouyang, Zimu Zhang, Ziyang Zeng, Jie Li, Weiming Kang · 2022 · Frontiers in Oncology
The upregulation of programmed death 1 on peripheral blood T cells of glioma is correlated with disease progression
Bo Wei, Le Wang, Xingli Zhao, Chao Du, Yongchuan Guo, Zhigang Sun · 2013 · Tumor Biology
Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma
Ilona Kryczek, Lin Wang, Ke Wu, Wei Li, Ende Zhao, Tracy Xiao Cui, Shuang Wei, Yan Liu, Yin Wang, Linda Vatan et al. · 2016 · OncoImmunology
PD-L1+ exosomes from bone marrow-derived cells of tumor-bearing mice inhibit antitumor immunity
Yan Sun, Jufeng Guo, Lei Yu, Tianxin Guo, Jiaoli Wang, Xian Wang, Yinghu Chen · 2020 · Cellular and Molecular Immunology
Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells
Chang-Yu Chen, Satoshi Ueha, Yoshiro Ishiwata, Shigeyuki Shichino, Shoji Yokochi, De Yang, Joost J. Oppenheim, Haru Ogiwara, Shungo Deshimaru, Yuzuka Kanno et al. · 2021 · Cancer Immunology Research
Potential approaches for more successful dendritic cell-based immunotherapy
Cheryl Lai-Lai Chiang, Klara Balint, George Coukos, Lana Elias Kandalaft · 2015 · Expert Opinion on Biological Therapy
T Cell Costimulatory and Inhibitory Receptors as Therapeutic Targets for Inducing Anti-Tumor Immunity
Jeurgen Foell, Becker Hewes · 2007 · Current Cancer Drug Targets
The emergence of immunomodulation: Combinatorial immunochemotherapy opportunities for the next decade
Lana Elias Kandalaft, Nathan Singh, John B. Liao, Andrea Facciabene, Jonathan S. Berek, Daniel J. Powell, George Coukos · 2009 · Gynecologic Oncology
Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer
Kristin L. White, David N. Rider, Kimberly R. Kalli, Keith L. Knutson, Gail Pairitz Jarvik, Ellen L. Goode · 2011 · Cancer Causes & Control
Targeting the programmed death-1 pathway in lymphoid neoplasms
Chi Young Ok, Ken H. Young · 2017 · Cancer Treatment Reviews
Cancer vaccine development: on the way to break immune tolerance to malignant cells
Simone Mocellin M. D, Carlo Riccardo Rossi, Donato Nitti · 2004 · Experimental Cell Research
TLR-mediated induction of negative regulatory ligands on dendritic cells
Stefan Gröschel, Kisha Piggott, Augusto Vaglio, Wei Ma-Krupa, Karnail Singh, Jörg J. Goronzy, Cornelia M. Weyand · 2008 · Journal of Molecular Medicine
Potentiation of therapeutic immune responses against malignancies with monoclonal antibodies.
Oihana Murillo, Ainhoa Arina, Iñigo Tirapu, Carlos Alfaro, Guillermo Daniel Mazzolini, Belén Palencia, Ascensión López-Dı́az de Cerio, Jesús Prìeto, Maurizio Bendandi, Ignacio Melero · 2003 · PubMed
Immunotherapy for gynaecological malignancies
George Coukos, Jose Ramon Conejo-Garcia, Richard B. S. Roden, T.‐C. Wu · 2005 · Expert Opinion on Biological Therapy
PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages
Michael Reginald Pitter, Ilona Kryczek, Hongjuan Zhang, Nisha Nagarsheth, Houjun Xia, Zhenyu Wu, Yuzi Tian, Karolina Okła, Peng Liao, Weichao Wang et al. · 2024 · Cell Reports
CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation‐Mediated c‐Myc Deubiquitylation to Facilitate Mutant TP53 Transcription
Z.H Wang, Yaming Li, Jingwen Yang, Yuhan Sun, Yinqiao He, Yuping Wang, Yiran Liang, Xi Chen, Tong Chen, Dianwen Han et al. · 2024 · Advanced Science
Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
Cécile Le Page, David D. Huntsman, Diane Michele Provencher, Anne‐Marie Mes‐Masson · 2010 · Cancers
Dendritic cell vaccines: A review of recent developments and their potential pediatric application
Jennifer D. Elster, Deepa Kolaseri Krishnadas, Kenneth G. Lucas · 2016 · Human Vaccines & Immunotherapeutics
Programmed death ligand 1 is expressed in canine B cell lymphoma and downregulated by MEK inhibitors
Senthil R. Kumar, Dae Young Kim, Carolyn J. Henry, Jeffrey N. Bryan, Katherine L. Robinson, Andrew Eaton · 2017 · Veterinary and Comparative Oncology
Inflammation and immunity in ovarian cancer
Diego Salas‐Benito, Enric Vercher, Enrique Conde, Javier Glez‐Vaz, Ibón Tamayo, Sandra Hervás‐Stubbs · 2020 · European Journal of Cancer Supplements
Sulforaphane Promotes Dendritic Cell Stimulatory Capacity Through Modulation of Regulatory Molecules, JAK/STAT3- and MicroRNA-Signaling
Yangyi Wang, Emilia Petrikova, Wolfgang Groß, Carsten Sticht, Norbert Gretz, Ingrid Herr, Svetlana Karakhanova · 2020 · Frontiers in Immunology
Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer
Kassidy Mikala Jungles, Erin A. Holcomb, Ashley N. Pearson, Kalli R. Jungles, Caroline R. Bishop, Lori J. Pierce, Michael D. Green, Corey Wayne Speers · 2022 · Frontiers in Oncology
Immunology of B7-H1 and Its Roles in Human Diseases
Hideto Tamura, Kíyoyuki Ogata, Haidong Dong, Lieping Chen · 2003 · International Journal of Hematology
Identification and molecular characterization of the interleukin-10 receptor 1 of the zebrafish (Danio rerio) and the goldfish (Carassius auratus L.)
Leon Grayfer, Miodrag Belosevic · 2011 · Developmental & Comparative Immunology
From Tumor Immunosuppression to Eradication: Targeting Homing and Activity of Immune Effector Cells to Tumors
Oana Draghiciu, Hans W. Nijman, Toos Daemen · 2011 · Clinical and Developmental Immunology
Immunologic aspect of ovarian cancer and p53 as tumor antigen
Hans W. Nijman, Annechien J.A. Lambeck, SH van der Burg, Agj van der Zee, Toos Daemen · 2005 · Journal of Translational Medicine
Effects of PD-1 Signaling on Immunometabolic Reprogramming
Vassiliki A. Boussiotis, Nikolaos Patsoukis · 2022 · Immunometabolism
Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements
Yang Wang, Na Zhu, Jing Liu, Fang Chen, Yang Song, Yue Ma, Zhuo Yang, Danbo Wang · 2025 · Journal of Translational Medicine
Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
Izabela Łasińska, Tomasz Kolenda, Anna Teresiak, Katarzyna Monika Lamperska, Łukasz Galus, Jacek Mackiewicz · 2018 · Anti-Cancer Agents in Medicinal Chemistry
CXCL9 secreted by tumor-associated dendritic cells up-regulates PD-L1 expression in bladder cancer cells by activating the CXCR3 signaling
Weigang Xiu, Jingjing Luo · 2021 · BMC Immunology
Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer
Huiru Zhang, Long‐Yun Ye, Xianjun Yu, Kaizhou Jin, Weiding Wu · 2022 · Frontiers in Immunology
Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition
Roger J. Daly, Andrew Mark Scott, Oliver Klein, Matthias Ernst · 2022 · Molecular Cancer
Multifunctional Non‐Viral Delivery Systems Based on Conjugated Polymers
Gaomai Yang, Fengting Lv, Bing Wang, Libing Liu, Qiong Yang, Shu Wang · 2012 · Macromolecular Bioscience
Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells.
P’ng Loke, James Patrick Allison · 2004 · Arthritis Research
Blocking PD-1 in cancer immunotherapy
Gianpietro Dotti · 2009 · Blood
Biomechanics of T Cell Dysfunctions in Chronic Diseases
Sachith D. Gunasinghe, Newton G. Peres, Jesse Goyette, Katharina Gaus · 2021 · Frontiers in Immunology
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy
Simone Ielpo, Francesca Barberini, Farnaz Dabbagh Moghaddam, Silvia Pesce, Chiara Cencioni, Francesco Spallotta, Adele De Ninno, Luca Businaro, Emanuela Marcenaro, Roberto Bei et al. · 2024 · Cancer Treatment Reviews
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells
Marino Paroli, Filippo Bellati, Melissa Videtta, Chiara Focaccetti, Carmine Mancone, Tiziana Donato, Morena Antonilli, Giorgia Perniola, Daniele Accapezzato, Chiara Napoletano et al. · 2013 · International Journal of Cancer
Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies
Jiri Keirsse, Helena Van Damme, Jo A. Van Ginderachter, Damya Laoui · 2017 · Journal of Leukocyte Biology
Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy
Misako Matsumoto, Yohei Takeda, Tsukasa Seya · 2020 · Expert Opinion on Biological Therapy
The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in Cancer
Christophe Glorieux, Xiaojun Xia, Peng Huang · 2021 · Cancers
Dendritic cell vaccination against ovarian cancer – tipping the Treg/TH17 balance to therapeutic advantage?
Martin J. Cannon, Hannah E. Goyne, Pamela J. B. Stone, Maurizio Chiriva‐Internati · 2011 · Expert Opinion on Biological Therapy
PD-1/PD-L1, MDSC Pathways, and Checkpoint Inhibitor Therapy in Ph(-) Myeloproliferative Neoplasm: A Review
Jen Chin C. Wang, Lishi Sun · 2022 · International Journal of Molecular Sciences
Sequential Intravesical Mitomycin plus Bacillus Calmette–Guérin for Non–Muscle-Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial
Robert Scott Svatek, Xiang R. Zhao, Edwin E. Morales, Mithilesh K. Jha, Timothy Y. Tseng, Cory Michael Hugen, Vincent J. Hurez, Javier Hernández, Tyler Jay Curiel · 2014 · Clinical Cancer Research